Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.

被引：0
|
作者：
Onyenadum, A [1 ]
Kosmidis, P [1 ]
Aravantinos, G [1 ]
Bafaloukos, D [1 ]
Gogas, H [1 ]
Bacoyiannis, C [1 ]
Razis, E [1 ]
Markopoulos, C [1 ]
Makatsoris, T [1 ]
Kalofonos, HP [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
829
引用
下载
收藏
页码：83S / 83S
页数：1
相关论文
共 50 条
  • [21] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    H J Stemmler
    D diGioia
    W Freier
    H W Tessen
    G Gitsch
    W Jonat
    W Brugger
    E Kettner
    W Abenhardt
    H Tesch
    H J Hurtz
    S Rösel
    O Brudler
    V Heinemann
    British Journal of Cancer, 2011, 104 : 1071 - 1078
  • [22] Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer
    Georgoulias, VA
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 18 - 24
  • [23] CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study
    Nooij, MA
    Steenland, E
    Beex, LVAM
    van de Bos, B
    Ruiter, L
    Haes, JCJM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S91 - S91
  • [24] Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
    Levy, C
    Fumoleau, P
    CANCER TREATMENT REVIEWS, 2005, 31 : S17 - S22
  • [25] Phase II trial of gemcitabine plus trastuzumab in minimally pretreated HER2 overexpressing metastatic breast cancer.
    Peacock, NW
    Bearden, J
    Schnell, F
    White, M
    Greco, FA
    Burris, HA
    Barton, JH
    Hainsworth, JD
    Spigel, DR
    Yardley, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 54S - 54S
  • [26] Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Patrizia Vici
    Alessandra Fabi
    Giulio Metro
    Domenico Sergi
    Diana Giannarelli
    Luigi Di Lauro
    Gerold Bepler
    Federica Tomao
    Francesco Cognetti
    Francesca Conti
    Massimo Lopez
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 687 - 693
  • [27] Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients
    Bilgin, T
    Özalp, S
    Yalçin, ÖT
    Zorlu, G
    Vardar, MA
    Özerkan, K
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (02) : 169 - 170
  • [28] ACCELERATED CHEMOTHERAPY WITH MITOXANTRONE PLUS G-CSF IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
    LORUSSO, V
    BERARDI, F
    TATULLI, C
    SARCINA, R
    DELENA, M
    ONCOLOGY REPORTS, 1994, 1 (03) : 591 - 595
  • [29] Phase II randomized study of gemcitabine plus vinorelbine versus gemcitabine plus mitoxantrone in advanced metastatic breast cancer elderly women: A first-line chemotherapy
    Latorre, A.
    Monticelli, G.
    Giotta, F.
    Calabrese, R.
    Lorusso, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII145 - VII146
  • [30] Gemcitabine plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Dong, Ningning
    Wu, Yongdong
    Song, Chenxin
    Wang, Mingyu
    Jiao, Yue
    Zhang, Shutian
    JOURNAL OF BUON, 2020, 25 (03): : 1348 - 1353
12345